Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04359836 · ClinicalTrials.gov registry record
A Study to Explore the Role of Gut Flora in COVID-19 Infection
A clinical trial of COVID-19 and Corona Virus Infection, sponsored by ProgenaBiome.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04359836: Recruiting study of COVID-19 and Corona Virus Infection, sponsored by ProgenaBiome.
NCT04359836 is a study of COVID-19 and Corona Virus Infection that is actively recruiting participants, run by ProgenaBiome. The registered enrollment target is 250 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04359836, a study of COVID-19 and Corona Virus Infection, is actively recruiting participants, sponsored by ProgenaBiome.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
Primary Outcome
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific gastrointestinal disease types.
Conditions Studied
Interventions
- OTHER There is no intervention in this study
Study Locations (1)
California
- ProgenaBiome - Ventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-04-16 |
| Est. Completion | 2027-07-31 |
What NCT04359836 shows while recruiting
NCT04359836 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 8 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention in this study is the first listed.
NCT04359836 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04359836 about?
NCT04359836 is a clinical study titled "A Study to Explore the Role of Gut Flora in COVID-19 Infection". This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
What is the current status of trial NCT04359836?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2020-04-16. Estimated completion is 2027-07-31.
What conditions does trial NCT04359836 study?
This clinical trial studies the following conditions: COVID-19, Corona Virus Infection, Gut Microbiome, Coronavirus, COVID.
What interventions are being tested in trial NCT04359836?
The interventions under investigation include: There is no intervention in this study (OTHER).
Who is sponsoring clinical trial NCT04359836?
This trial is sponsored by ProgenaBiome, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04359836 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04359836's enrollment target sits among peer trials
250 149th of 298 higher than 150 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI